Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$6.87 - $11.11 $2,335 - $3,777
-340 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$7.7 - $37.13 $1.49 Million - $7.2 Million
-193,848 Reduced 99.82%
340 $3,000
Q3 2021

Nov 10, 2021

SELL
$26.46 - $37.15 $102,664 - $144,142
-3,880 Reduced 1.96%
194,188 $6.6 Million
Q2 2021

Aug 10, 2021

SELL
$32.73 - $47.95 $131,247 - $192,279
-4,010 Reduced 1.98%
198,068 $7.25 Million
Q1 2021

May 11, 2021

BUY
$40.39 - $56.73 $8.16 Million - $11.5 Million
202,078 New
202,078 $9.06 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Gw&K Investment Management, LLC Portfolio

Follow Gw&K Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.